These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Management of severe synovial arthritis with drugs]. Korpela M Duodecim; 2004; 120(6):707-14. PubMed ID: 15119232 [No Abstract] [Full Text] [Related]
28. [Effect of immunosuppressive agents on nucleic acid and nucleotide metabolism in rheumatoid arthritis (experimental and clinical study)]. Matulis AA; Mishkinite GA; Kurtinite GP; Tamakauskene GI; Snechkene LI Vopr Revm; 1974; (2):61-7. PubMed ID: 4409366 [No Abstract] [Full Text] [Related]
29. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model. Wolfe F; Caplan L; Michaud K J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626 [No Abstract] [Full Text] [Related]
30. [Recent methods of drug therapy in rheumatoid arthritis]. Günther R Beitr Rheumatol; 1968; 13():75-87. PubMed ID: 5728436 [No Abstract] [Full Text] [Related]
31. [Effectiveness and safety of immunosuppressive agents in the treatment of rheumatoid arthritis]. Carreira Delgado PE; Gómez-Reino Carnota JJ; Morillas López L; Ibero Díaz I; Mateo Bernardo I Med Clin (Barc); 1986 Apr; 86(14):575-8. PubMed ID: 3724263 [No Abstract] [Full Text] [Related]
33. [Immunosuppressive therapy in primary chronic polyarthritis]. Warnatz H Verh Dtsch Ges Inn Med; 1972; 78():771-4. PubMed ID: 4665752 [No Abstract] [Full Text] [Related]
34. [Humoral and cellular immunopathology of rheumatoid arthritis. II. Quantitative cellular immunity]. Martín Mola E; Cabarcos Cazón A; Imizcoz JL; Pérez Miranda M Rev Med Univ Navarra; 1980 Dec; 24(4):43-8. PubMed ID: 6977801 [No Abstract] [Full Text] [Related]
35. [Use of antilymphocyte globulin in the treatment of rheumatoid arthritis]. Iannotta F; Fantini F; Colombo B Minerva Med; 1974 Jan; 65(5):241-8. PubMed ID: 4856472 [No Abstract] [Full Text] [Related]
36. [Epitheliotrophic capacity of serum eye drops from healthy donors versus serum from immunosuppressed patients with rheumatoid arthritis]. Harloff S; Hartwig D; Kasper K; Wedel T; Müller M; Geerling G Klin Monbl Augenheilkd; 2008 Mar; 225(3):200-6. PubMed ID: 18351533 [TBL] [Abstract][Full Text] [Related]
37. [Symposium II. 4-1. Long-term immunosuppressive therapy for rheumatoid arthritis]. Kobayashi I; Imura S Ryumachi; 1973 Jan; 13(1):48-9. PubMed ID: 4726792 [No Abstract] [Full Text] [Related]
38. [Lymphocyte subpopulations in patients with rheumatoid arthritis after anti-inflammatory and immunosuppressive treatment]. Drozd C Reumatologia; 1983; 21(1):33-7. PubMed ID: 6606203 [No Abstract] [Full Text] [Related]
39. [Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases]. Vignon G; Bied JC Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):785-95. PubMed ID: 5152712 [No Abstract] [Full Text] [Related]